Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Rinvoq (upadacitinib)
Pharma
AbbVie settles lawsuit to ward off Rinvoq generics until 2037
AbbVie is working to cover its legal bases so the drug can make the most of its U.S. market exclusivity.
Fraiser Kansteiner
Sep 11, 2025 1:36pm
AbbVie's Rinvoq passes midstage test in SLE
May 31, 2023 10:16am
Intra-Cellular winner of the Fierce Madness Drug Ad Tournament
Mar 22, 2023 8:30am
AbbVie's immunology stalwart Skyrizi clinches a 3rd indication
Jun 17, 2022 11:01am
Dupixent leads TV ad spending for 2nd month in a row
Jun 8, 2022 10:00am
Dupixent retakes TV ad spending crown from AbbVie's Rinvoq
May 6, 2022 12:31pm
